Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Clinical Services and DataLabs Announce EDC Partnership

WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 17, 2005--The Clinical Services division of Charles River Laboratories International, Inc. (NYSE:CRL) (Charles River) and DataLabs are pleased to announce an EDC partnership to utilize the latest version of DataLabsXC(TM) electronic clinical data management (eCDM) software solution for capturing and managing clinical trial data.

Charles River offers a best-of-breed suite of Integrated Clinical Technologies(TM) for managing global clinical trials, including customized interactive voice response (IVR) and web applications, comprehensive clinical trial management systems (CTMS) and drug safety and pharmacovigilance systems. "The integration of the DataLabsXC(TM) eCDM system into our Integrated Clinical Technologies(TM) platform offers our customers an extremely powerful solution," said General Manager, Global Clinical Services, Christophe Berthoux, DVM. "DataLabs' technology dovetails perfectly with our strategy to bring together the highest quality services and exceptional technology to assist our customers in developing products faster and more efficiently."

"We are very pleased to have Charles River Laboratories join our CRO Partners Program," said DataLabs President, James Langford. "DataLabs has become the leading software company for the CRO industry by providing significant value in both our software and in our business model. We recognize that for CROs to be able to provide value to their clients, software providers need to deliver a single clinical data management platform that can be easily installed and integrated in our client's environment. Since we are a software company, technology transfer and support of our software is our primary focus, and this business model is resonating within the CRO industry."

"Our success relies on our ability to share information among all our stakeholders in the clinical trial process with flexibility, speed and accuracy," said Vice President Global Medical Data Sciences Jim Esinhart, Ph.D. "DataLabs is a significant addition to our data capture techniques. A critical strength of the platform is the single unified EDC and traditional paper-CRF platform. Additionally, the technology transfer philosophy allows us to provide an immediate hosted capability with the flexibility to later deploy as an internal enterprise solution."

About Charles River Laboratories

Charles River Laboratories, based in Wilmington, Massachusetts, is a global provider of solutions that advance the drug discovery and development process. Our leading-edge products and services are designed to enable our clients to bring drugs to market faster and more efficiently. Backed by our rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, our products and services are organized into three categories spanning every step of the drug development pipeline: Research Models and Services, Preclinical Services, and Clinical Services. Charles River's customer base includes all of the major pharmaceutical companies and many biotechnology companies, government agencies and leading hospitals and academic institutions. Charles River's 8,000 employees serve clients in more than 50 countries. For more information on Charles River, visit our website at www.criver.com.

About DataLabs

DataLabs is the leading software company to the CRO industry providing innovative Internet-based applications for clinical development that helps the CRO and biopharmaceutical industries accelerate clinical trials with proven software for study design, data capture and data management. Based on Microsoft platform technology, XML Web services and CDISC ODM standards, the DataLabsXC product suite adapts to established operating procedures and integrates easily with existing technology systems. As a result, DataLabsXC customers enjoy a low total cost of ownership and high return on investment. Major pharmaceutical companies, government entities, healthcare organizations and contract research organizations are currently realizing time and cost savings using DataLabsXC. DataLabs, a Microsoft Certified Partner, is based in Irvine, Calif. with East Coast offices in Pennsylvania. For more information, please visit www.datalabs.com.

CONTACT: Charles River Laboratories
Elizabeth Ferber, 978-658-6000 ext. 1693
Director, Global Communications
F: 978-658-7841
corpcomm@crl.com

SOURCE: Charles River Laboratories

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)